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Abstract
Background: Systemic leukocyte activation and disseminated leukocyte adhesion will impair the microcirculation and cause
severe decrements in tissue perfusion and organ function in the process of severe sepsis. Gu-4, a lactosyl derivative, could
selectively target CD11b to exert therapeutic effect in a rat model of severe burn shock. Here, we addressed whether Gu-4
could render protective effects on septic animals.
Methodology/Principal Findings: On a murine model of endotoxemia induced by lipopolysaccharide (LPS), we found that
the median effective dose (ED50) of Gu-4 was 0.929 mg/kg. In vivo treatment of Gu-4 after LPS challenge prominently
attenuated LPS-induced lung injury and decreased lactic acid level in lung tissue. Using the ED50 of Gu-4, we also
demonstrated that Gu-4 treatment significantly improved the survival rate of animals underwent sepsis induced by cecal
ligation and puncture. By adhesion and transwell migration assays, we found that Gu-4 treatment inhibited the adhesion
and transendothelial migration of LPS-stimulated THP-1 cells. By flow cytometry and microscopy, we demonstrated that Gu-
4 treatment inhibited the exposure of active I-domain and the cluster formation of CD11b on the LPS-stimulated
polymorphonuclear leukocytes. Western blot analyses further revealed that Gu-4 treatment markedly inhibited the
activation of spleen tyrosine kinase in LPS-stimulated THP-1 cells.
Conclusions/Significance: Gu-4 improves the survival of mice underwent endotoxemia and sepsis, our in vitro
investigations indicate that the possible underlying mechanism might involve the modulations of the affinity and avidity
of CD11b on the leukocyte. Our findings shed light on the potential use of Gu-4, an interacting compound to CD11b, in the
treatment of sepsis and septic shock.
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Introduction
Sepsis, severe sepsis and septic shock, the leading causes of
death in surgical intensive care unit patients, are characterized by
pathological changes within the microcirculation [1]. Impairment
of the microcirculation causes severe decrements in tissue
perfusion and organ function and plays a vital role in the
progression to severe sepsis [2,3]. Observations from various
experimental models of sepsis, such as endotoxemia and cecal
ligation and puncture (CLP), have suggested that the represen-
tative event that takes place within microcirculation is the
increase of rolling and adhering leukocytes in small blood vessels
[4,5,6]. Hence, systemic leukocyte activation and disseminated
leukocyte adhesion are regarded to be essential for septic organ
dysfunction.
Many phagocytic components (neutrophils/macrophage/
monocytes) of the immune system as well as non-immune cells
(epithelia, endothelia, etc.) express TLR4 and its associated
lipopolysaccharide (LPS) receptor complex [7]. When challenged
by LPS, the component of the outer membrane of Gram-negative
bacteria, this phagocytic system will respond with an exaggerated
inflammatory mediator release. In turn, inflammatory mediators
together with LPS induce the upregulation of adhesion molecules
and promote the adhesion of leukocytes to endothelium [8,9]. The
initial capture and rolling of leukocytes on the activated
endothelium are mediated by selectins. Selectin-interactions and
local chemokines activate leukocyte integrins, such as lymphocyte
function-associated antigen-1 (LFA-1, CD11a/CD18) and macro-
phage antigen-1 (MAC-1, CD11b/CD18), which favour interac-
tions with endothelial counter-receptors, such as intercellular
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[10,11].
Because of their direct linkage with the consequences of sepsis,
adhesion molecules that mediate leukocyte adhesion become ideal
drugable targets for treating this disease [12,13]. Numerous
antagonists directed at adhesion molecules have been prepared
and some of them showed promising therapeutic effects in clinical
trials for inflammatory diseases [14]. Unfortunately, so far there is
no effective antagonist against adhesion molecule has been used
for the treatment of sepsis. The currently recommended therapies
for the treatment of sepsis are multifaceted, including timely
diagnosis, early antimicrobial therapy, ventilation, goal-directed
hemodynamic support, targeted immunological therapy and
effective supportive therapies. Despite timely intervention, these
treatment strategies are unable to abrogate sepsis pathophysiology,
and sepsis associated mortality rates remain unacceptably high
[15,16].
Our earlier studies have demonstrated that a lactosyl derivative
named Gu-4 (N-[2-(1, 3-dilactosyl)-propanyl]-2-amino-pentandia-
mide) could selectively target CD11b to exert therapeutic effect in
a rat model of severe burn shock [17]. However, whether this
tetravalent lactoside could benefit other inflammatory diseases is
not clear and, importantly, the precise role of Gu-4 in the
interfering with the function of CD11b remains largely unknown.
In the present study, we extensively investigated the therapeutic
effects of Gu-4 in a murine lethal endotoxemia model induced by
LPS and in a sepsis model induced by CLP. We found that Gu-4
obviously protected animals from mortality caused by septic shock,
and our findings from in vitro experiments suggested that the
decrease of the affinity and avidity of CD11b may be one of the
possible underlying mechanisms.
Results
Gu-4 increases survival rate but does not affect
expression profiles of plasma TNF-a and IL-10 in LPS-
induced shock model
To investigate the role of Gu-4 in protecting mice from
endotoxemia and to determine the median effective dose (ED50)
of Gu-4 for the survival of LPS-induced endotoxemic mice, we
performed a dose-response study with incremental doses of Gu-4
(1.2 fold increments). As shown in Figure 1A, the starting dose of
Gu-4 tested (0.74 mg/kg) had no effect, while the following doses
markedly improved the survival (p,0.05 vs. saline control) and at
dose of 1.27 mg/kg, Gu-4 exhibited the highest efficacy. The
ED50 of Gu-4 for this murine model is 0.929 mg/kg as estimated
using Probit analysis. In addition, Gu-4 treatment alone did not
show any hazardous effect on mice. By contrast, neither b-lactose
nor dexamethasone showed significant protective effect on
endotoxemic mice (p.0.05 vs. saline control).
Tumour necrosis factor a (TNF-a) is a pro-inflammatory
cytotoxin that has been implicated in septic shock, while
interleukin-10 (IL-10) is an anti-inflammatory cytokine capable
of inhibiting synthesis of TNF-a [18,19,20]. Therefore, we
determined the effect of Gu-4 on the expression profiles of
circulating TNF-a and IL-10 in the LPS-induced endotoxemic
mice. As shown in Figure 1B and C, both the plasma TNF-a and
IL-10 increased to the maximum level at about 1 hr after LPS
challenge, and declined gradually thereafter. In endotoxemic mice
treated with Gu-4, there was no obvious change in the expression
profiles of TNF-a and IL-10 at the dose of 0.929 mg/kg,
indicating that Gu-4 achieves its survival benefit through some
other ways but not through affecting the expression of TNF-a or
IL-10 in serum.
Gu-4 attenuates the organ injury and the increase of LA
level in lung of LPS-induced shock model
Among the vital organs in the body, the lung is particularly
susceptible to acute injury in LPS- induced endotoxemia [21]. To
determine whether Gu-4 could protect mice underwent septic
shock from acute acute injury, we performed histological
examinations and analyzed the effect of Gu-4 treatment on
leukocyte infiltration in lung tissues. In comparison with the
architectures of lung from saline treated normal mice (Figure 2A),
lung tissues from LPS-treated mice exhibited severe edema and
infiltration of the inflammatory cells and granulocytes (Figure 2B).
By contrast, granulocytes infiltration and edema were obviously
attenuated in lungs after in vivo administration of Gu-4 (0.929 mg/
kg, i.v.) (Figure 2C). We then evaluated the lung injury on
histological sections using a semi-quantitative scale (detailed
described in Materials and Methods). As shown in Figure 2D,
the total injury score in lungs after LPS challenge increased
dramatically compared to saline treated ones, while the score
decreased markedly almost to the normal level after in vivo
administration of Gu-4.
Since severe histological damage and leukocytes infiltration
resulted from LPS challenge could lead to metabolic deterioration
[22,23], we thus examined the lactic acid (LA) level in lungs of
mice with different treatments. As shown in Figure 2E, LPS
stimulation for 10 hrs induced a statistically significant elevation of
LA level compared to control treatment (p,0.05, LPS vs. saline
challenge), while the increase of LA level was significantly
attenuated after the administration of Gu-4 to the LPS challenged
mice (p,0.05, Gu-4 vs. LPS).
Gu-4 blocks the adhesion and transendothelial migration
of THP-1 cells
Since histological examinations showed that Gu-4 attenuated
the leukocytes infiltration, we thus employed in vitro adhesion and
transwell assays to deeply investigate the activity of Gu-4. In
adhesion assay, the adhesion of LPS-untreated THP-1 cells to
HUVECs appeared no observable difference among different
treatments, namely, treatment of saline, Gu-4, b-lactose, or
treatment of CD11b antibody (Figure 3A). By contrast, upon
LPS stimulation, THP-1 cells exhibited an obvious increase in
adhesion. Markedly, the adhesive activities of cells treated with
Gu-4 and CD11b antibody, but not b-lactose, dramatically
decreased (Figure 3A).
The results of transwell experiments were consistent with those
observed in adhesion assay. In response to a chemotactic gradient
of IL-8, a nearly 50% reduction of migration activity was achieved
in THP-1 cells treated with Gu-4 or CD11b antibody as compared
to those cells treated with saline (Figure 3B). No obvious difference
in cell migration activities was observed between the b-lactose
treatment and saline treatment.
Effects of Gu-4 on the expression and distribution of
CD11b
We have previously identified CD11b, an integrin on the
surface of leukocyte, as a target molecule of Gu-4 [17], but the
precise role of Gu-4 in the interfering with the function of
CD11b remains largely unknown. Since affinity and avidity
regulations are the main mechanisms that regulate the function
of CD11b in the process of inflammation [24,25], we thus
examined the expression and distribution of CD11b and its
active ‘‘I-domain’’ in the leukocytes isolated from the whole
blood by flow cytometry and confocal microscopy. Under
normal conditions, CD11b and its I-domain are expressed at a
Gu-4 Suppresses the Affinity and Avidity of CD11b
PLoS ONE | www.plosone.org 2 February 2012 | Volume 7 | Issue 2 | e30110low level and distributed unevenly on the surface of neutrophils
(Figure 4A, B; Figure 5B, D). Gu-4 alone did not change the
expression and distribution styles of CD11b (Figure 4A, B;
Figure 5F, H). However, when cells were exposed to LPS, the
amount of CD11b and its I-domain on neutrophils was greatly
increased, and both of them redistributed on the cell membrane
to form clusters (Figure 4A, B; Figure 5J, L). To the LPS-
stimulated cells, Gu-4 showed more potent inhibitory effect on
the exposure of CD11b I-domain than on the expression of
CD11b itself (Figure 4A, B). Interestingly, changes of redistri-
bution of CD11b (Figure 5N vs. J) and CD11b I-domain
(Figure 5P vs. L) were significantly blocked by Gu-4. We
speculated that Gu-4 attenuates leukocyte adhesion and
subsequent transendothelial migration through blocking the
activation and the formation of clusters of CD11b on the
membrane.
Gu-4 blocks the activation of Syk in LPS-stimulated THP-1
cells
To confirm the potent inhibitory effect of Gu-4 to the activation
of CD11b in the LPS-stimulated leukocytes, we further examined
the expression of downstream effector responsible for CD11b
signaling transduction in the THP-1 cells. By Western blot
analysis, we determined the expression of spleen tyrosine kinase
(Syk), an important signaling molecule for signal-transduction of
integrin outside-in signaling [26]. As shown in Figure 6A and B,
the expression level of phosphorylated Syk in the THP-1 cells
initiated to increase at time point of 5 min immediately after LPS
stimulation and sustained at the later time points (10, 15, 20 min),
while Syk protein level was unchanged. However, the LPS-
triggered increase of Syk phosphorylation was attenuated by the
combined LPS and Gu-4 treatment. Gu-4 treatment alone did not
induce Syk activation or Syk upregulation in the THP-1 cells. This
result demonstrated that Gu-4 treatment provided strong blockade
on the activation of CD11b.
Gu-4 improves survival in polymicrobial sepsis
The model of cecal ligation and puncture (CLP) is a well
established polymicrobial sepsis model, which has been demon-
strated to be the most representative animal model of human
sepsis [27,28], we therefore investigated whether Gu-4 also have
protective effects on animals after CLP. CLP treatment resulted in
a 90% mortality by the end of observation (72 hrs). While using
the ED50 dose of Gu-4 for septic mice, administration of Gu-4 at
the dose of 0.929 mg/kg per 3 hrs significantly improved the
survival of mice after CLP (p,0.05, Gu-4 vs. saline) (Figure 7),
demonstrating that Gu-4 has an effective therapeutic activity in
polymicrobial sepsis, a inflammatory response occurring in
humans.
Figure 1. Effects of Gu-4 on survival and expression profiles of
TNF-a and IL-10 in septic mice. A: Survival of septic mice induced by
LPS stimulation (37.5 mg/kg i.p.) (n=10 in each group) was monitored
for 72 hrs. Gu-4 administration significantly reduced LPS-induced
mortality at the doses of 0.88, 1.06, 1.27 and 1.53 mg/kg. *: p,0.05
indicates a significant decrease in mortality by Gu-4 treatment versus
saline treatment as determined by log-rank test. b-lactose or
dexamethasone (Dex) did not produce significant improvement in
survival. B and C: Serum levels of TNF-a and IL-10 were measured in
groups of mice killed at 0 (baseline), 1, 2, 4, 6, 8 and 10 hr after LPS
stimulation, respectively. Both TNF-a (B) and IL-10 (C) productions
increased to the maximum level at about 1 hr after LPS injection and
then declined. Administration of Gu-4 at the ED50 dose of 0.929 mg/kg
did not affect TNF-a or IL-10 expression profile in serum. Data shown
represent mean 6 SD of n=10 animals at each time point. Gu-4-alone
represents that the mice treated with Gu-4 alone at the dose of 10 mg/
kg. No adverse effects were observed in this group (i.e., 100% survival),
and Gu-4 treatment at this dose did not affect baseline level of TNF-a or
IL-10.
doi:10.1371/journal.pone.0030110.g001
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Progressive organ damage and dysfunction occurred in septic
patients are closely correlated with systemic leukocyte activation
and disseminated leukocyte adhesion [29,30]. The currently
available supportive therapeutic interventions can not prevent or
reverse organ damage, which underlined an urgent need for
specific therapeutic treatments. In this study, we examined the role
of Gu-4, a lactosyl derivative, which had been successfully
synthesized and demonstrated to be a specific inhibitor of
leukocyte integrin CD11b, in protecting mice underwent endo-
toxemia or polymicrobial sepsis from mortality and the underlying
mechanism involved in this role. We found that this compound
greatly inhibited the activation and cluster formation of CD11b on
the membrane of LPS-stimulated leukocyte. This result made it
understandable that Gu-4 treatment protected animals from
mortality and acute lung injury in LPS-induced and CLP-induced
septic shock models.
Normally, the inflammation response of innate immune system
toward invading pathogens is tightly regulated [31]. However, in
the situation like experimental endotoxemia in which the
inflammatory stimuli (such as LPS) are intense, inflammatory
mediators are produced in an unregulated manner. The cascade of
cytokine and chemokine production will lead to uncontrolled
leukocyte infiltration and activation that damage the tissue leading
to organ dysfunction. Although these events can affect all tissues of
the organism, the lung appears to be primary target. In this study,
firstly we analyzed the effect of different Gu-4 doses on survival
rate. The lowest dose of the compound tested was ineffective in
terms of survival benefit, whereas at the incrementally higher doses
tested, the statistically significant therapeutic benefit appeared,
suggesting that proper and sufficient amount of Gu-4 is necessary
to produce the therapeutic effects. Interestingly, at ED50 dose of
0.929 mg/kg as estimated by Probit analysis, Gu-4 did not alter
the expression profiles of plasma proinflammatory cytokine TNF-a
or anti-inflammatory cytokine IL-10, suggesting that the biological
effects of Gu-4 on septic shock did not directly correlated with the
inhibition of the early inflammatory mediator release. We thus
speculated that Gu-4 might play its roles by being involved in the
process of cell adhesion and migration. Subsequently, we analyzed
the effects of Gu-4 on leukocytes infiltration histologically in the
lung tissues in vivo and on adhesion and migration of THP-1 cells in
vitro. Histological examinations of lung tissues revealed that
leukocyte infiltration and injury were markedly attenuated by
Gu-4 treatment compared to vehicle treatment. In addition, in vitro
Gu-4 treatment inhibited the adhesion and migration of LPS-
stimulated THP-1 cells to HUVECs. Therefore, it is conceivable
that attenuated leukocyte infiltration in lung tissue should be
attributed to the attenuated adhesion and migration of leukocytes
affected by Gu-4 administration through circulation, thereby
attenuating the inflammatory response induced by LPS and
protecting animals from septic shock.
Under the condition of shock, the imbalance of oxygen
demands and oxygen supply will lead to tissue hypoxia and the
subsequent increase of lactate production. The amount of
produced lactate is generally believed to be correlate with the
total oxygen debt, the magnitude of hypoperfusion, and the
severity of shock [32,33]. One of the proposed mechanisms for the
deficient oxygen delivery in sepsis is the occlusion of capillaries
[34]. Accumulating evidences to date support that leukocyte is a
likely candidate to occlude capillaries [35]. Therefore, we
examined the LA level in the lung tissues and found that a
significant increase of LA was observed in lung tissues from LPS-
stimulated mice but not from LPS-stimulated mice with Gu-4
treatment. The lung administrated with Gu-4 after LPS challenge
exhibited the normal architectures and the attenuated leukocyte
Figure 2. Effects of Gu-4 on lung injury and LA level of lung tissue in septic mice. A: Lung tissues from saline-treated mice exhibited normal
architectures. B: Lung tissues from LPS-challenged mice showed severe edema and leukocyte infiltration as indicated with black arrows. C: Lung
tissues from Gu-4-treated LPS-challenged mice showed normal architectures and significant decrease of inflammatory cell infiltration. D: Semi-
quantitative scoring of lung injury was determined as described in Materials and Methods. The lung injury was seriously induced by LPS but was
attenuated by Gu-4. E: LA level in lung tissue from septic mice is significantly higher than those from normal mice and Gu-4-treated LPS- challenged
mice. Magnification: 6200. *: p,0.05 vs. Normal; #:p ,0.05 vs. LPS + Saline.
doi:10.1371/journal.pone.0030110.g002
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the occlusion of capillaries caused by the enhanced adhesion of
leukocytes in sepsis. Obviously, these data strengthened our
conclusion of the therapeutic values of Gu-4 in treatment of septic
shock. In addition, our results also support the notion that early
lactate clearance is associated with improved outcome in severe
sepsis and septic shock [32,33].
The firm adhesion of leukocytes to endothelial cells and the
transendothelial migration were mainly mediated by b2 integrins
and their ligands [11]. These molecules are heterodimers that
share a common b subunit (CD18) with distinct a subunits such as
CD11b, whose activity is tightly controlled. There are two distinct
mechanisms had been proposed to explain the activation of
integrin. The first mechanism suggests that alterations in the
affinity of integrins lead to enhanced ligand binding. It is believed
that a distal N-terminal extracellular ‘‘I-domain’’ is critical for
ligand binding in each of these two subunits [24]. The usually
embedded ‘‘I-domain’’ of a subunit undergoes a conformation
change in response to inflammation, leading to the activation of
integrin. The conformation change or exposure of ‘‘I-domain’’ will
Figure 3. Gu-4 inhibited the adhesion and subsequent
transendothelial migration of THP-1 cells. HUVECs and calcein
AM-labeled THP-1 cells were pretreated as described in Material and
methods and subjected to adhesion and migration assays. A: In
adhesion assay, THP-1 cells with LPS stimulation showed enhanced
adhesion to HUVECs, whereas THP-1 cells treated with Gu-4 or CD11b
antibody, but not b-lactose, after LPS stimulation showed no significant
increase of adhesion compared with control cells. The experiments
were performed in triplicate. *: p,0.05 vs. LPS (2) control. #:p ,0.05
vs. LPS (+) control. B: In migration assay, LPS-stimulated THP-1 cells were
subjected to treatments of Gu-4, b-lactose, CD11b antibody, or saline,
and then seeded into inserts with HUVECs monolayer on the outer side
of the membrane. The relative amount of migrated cells in the lower
chamber were determined by measurement of fluorescence intensity.
Both Gu-4 and CD11b antibody significantly reduced the migration of
THP-1 cells across HUVECs monolayer. The experiments were performed
in triplicate. *: p,0.05 vs. saline.
doi:10.1371/journal.pone.0030110.g003
Figure 4. Effects of Gu-4 on the expression of CD11b and the
exposure of CD11b active I-domain. In the presence or absence of
Gu-4 (40 nmol/ml), whole blood samples from healthy donors were
firstly stimulated with or without LPS (100 ng/ml) for 30 mins, then the
samples were co-incubated with saturating amounts of PE conjugated
CBRM1/5 or PE labeled anti-CD11b antibody sc-1186 for 10 mins,
respectively. After removal of red blood cells, different populations of
leukocytes were identified by flow cytometry. A: Expression of CD11b
active I-domain. Upon LPS stimulation, CD11b active I-domain on
neutrophils was greatly increased, but could be markedly supressed by
Gu-4 treatment. B: Expression of CD11b. CD11b expression was
significantly elevated in LPS-stimulated neutrophils. Gu-4 showed weak
inhibitory effect on such elevation. Data represented the results of
triplicate experiments. *: p,0.05.
doi:10.1371/journal.pone.0030110.g004
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mechanism suggests that the avidity of integrins is increased as a
result of increased cluster formation of cell surface receptors
[25,36]. In the present study, we examined the effects of Gu-4 on
the affinity and avidity modulations of CD11b. The LPS-induced
exposure of CD11b ‘‘I-domain’’ and the cluster formation of
CD11b/CD18 were significantly inhibited by Gu-4 treatment.
Thus, these results implied a possible underlying mechanism for
the inhibitory effect of Gu-4 on leukocyte adhesion, that is, Gu-4
targets to CD11b and inhibits the conformation change of CD11b
Figure 5. Effects of Gu-4 on the distribution of CD11b and CD11b active I-domain on leukocytes. Leukocytes obtained and treated as
described in flow cytometry study were further incubated with Qdot 655 secondary antibody and observed by using a laser scanning confocal
microscope. Cells with diameters about 10 mm were imaged and displayed in a pseudo 3D mode (2.5D filled view). Images in the panels of ‘‘light’’
show representative cells acquired under bright field, and those in the other two panels illustrate the mesh plots of fluorescence intensity vs. spatial
distribution of CD11b and its active I-domain on the corresponding cell in the juxtaposed image. Gu-4 greatly diminished the exposure of CD11b
active I-domain in LPS-stimulated leukocyte (P vs. L). The increased expression of CD11b in LPS-stimulated leukocyte was not markedly affected by
Gu-4, but the clustering of CD11b was partly inhibited (J vs. N). Original magnification, 6630.
doi:10.1371/journal.pone.0030110.g005
Figure 6. Effects of Gu-4 on activation of Syk in LPS stimulated THP-1 cells. A: Western Blot analyses of Syk and phosphorylated Syk (p-Syk)
in THP-1 cells stimulated with LPS alone (100 ng/ml), LPS (100 ng/ml) plus Gu-4 (40 nmol/ml), or Gu-4 alone (40 nmol/ml) for 0 to 20 mins; b-actin
serves as a loading control. B: The densitometric analyses showed that LPS-induced increase of phosphorylation of Syk was markedly blocked by Gu-
4. These statistical data were from 5 independent experiments. *: p,0.05 vs. the LPS + Gu-4 or Gu-4 treated group at indicated time point. #:p ,0.05
vs. time point of 0 min.
doi:10.1371/journal.pone.0030110.g006
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leukocytes.
It has been reported that the therapeutic uses of ligand mimetic
integrin antagonists have paradoxically enhanced integrin
function and worsened some clinical outcomes [37]. Because
ligand binding merely shifts the conformational equilibrium
toward the fully active state of integrin, and the active as well as
high-affinity conformation is sufficient to induce outside-in
signaling. In addition, through ITAM-coupled activation of the
nonreceptor tyrosine kinase Syk pathway, outside-in signaling can
regulate a variety of cellular properties such as cell shape,
migration, cytotoxicity, growth, and survival. These evidences
suggest that antagonists which inducing integrin conformation
changes or initiating outside-in integrin signaling are not suitable
for clinical use, no matter how effective their antagonistic
activities are. While in our study, we showed that the LPS-
triggered activation of Syk was potently blocked by Gu-4,
demonstrating that Gu-4 binded to CD11b and blocked its
activation without touching the outside-in signaling in the
cytoplasm. In this sense, we believe that Gu-4 provides more
therapeutic value in treatment of sepsis than conventional
antagonists against CD11b.
Sepsis and septic shock are very harmful disorders with
complicated mechanisms. Endeavour to alleviate the adhesion
between leukocyte and endothelial cells has been considered as an
alternative way for the treatment of septic shock besides
conventionally adopted interventions. Although the understanding
of underlying mechanisms by which Gu-4 protects mice from
endotoxemia and sepsis requires systemic investigation, our in vitro
data support the hypothesis that Gu-4 inhibits the leukocyte-
endothelial cell adhesion by modulation of the affinity and avidity
of leukocyte integrin CD11b and alleviates the inflammatory
response and organ injury, thereby providing therapeutic effects to
animals. Importantly, our findings shed light on the potential use
of Gu-4, an interacting compound to CD11b, in the treatment of
sepsis and septic shock.
Materials and methods
Ethics statement
This study was carried out in strict accordance with the
requirements of Provisions and General Recommendation of
Chinese Experimental Animals Administration Legislation and
were approved by Science and Technology Department of Jiangsu
Province [Permit Number: SYXK (Su) 2010-0003]. All surgeries
were performed under sodium pentobarbital anesthesia, and all
efforts were made to minimize suffering. Blood samples of healthy
donors were purchased from Jiangsu Province Blood Center and
approved by the Blood Donation Office of Jiangsu Province and
College of Life Science, Nanjing Normal University (Permit
Number: 037).
Preparation of Gu-4
Endotoxin-free lactosyl derivative Gu-4 was prepared in our
laboratory and confirmed by nuclear magnetic resonance (NMR),
mass-spectrometry (MS), elemental analysis and Limulus Amebo-
cyte Lysate assay.
Cell culture
Human umbilical vein endothelial cells (HUVECs) obtained
from ScienCell were grown in endothelial cell medium (ECM,
1001, ScienCell) with 1% endothelial cell growth supplement
(ECGS, 1052, ScienCell). All experiments with HUVECs were
performed below 8 passages. THP-1 cells (human acute monocytic
leukemia cell line) were purchased from the CBCAS (Cell Bank of
the Chinese Academic of Sciences, Shanghai, China) and
maintained in RPMI1640 (GIBCO) supplemented with 15% (v/
v) fetal bovine serum. All cells were maintained at 37uCi na
humidified 5% CO2 incubator.
Effect of Gu-4 in the LPS model of endotoxemia
Eight-week-old ICR mice (Shanghi Laboratory Animal Center,
Chinese Academy Sciences, Shanghai, China) were used in this
study. Mice were injected i.p. with freshly prepared LPS (7.5 mg/
ml, Sigma, Escherichia coli O111:B4) dissolved in saline solution at
the dose of 37.5 mg/kg to induce endotoxemia [38]. All drugs
used for treatment were dissolved in saline solution and given
through tail vein injection at 30 mins after LPS challenge
(0.005 ml/g), saline solution was used as a control treatment.
After separately treated with incremental doses of Gu-4 (0.74,
0.88, 1.06, 1.27, or 1.53 mg/kg), b-lactose (0.27 mg/kg) (Sigma,
L3750), dexamethasone (1.3 mg/kg) (Jinling Pharmaceutical,
China), or saline, the animals were returned to their cages and
fed ad libitum. The death of animal was determined by rigorous
physical examinations, including no response to pain, no corneal
reflex and no spontaneous respirations. The survival rate was
studied in n=10 mice in each group. An additional group of mice
(n=10) received Gu-4 alone (10 mg/kg) without LPS treatment
was designed as control. A total of 80 mice was used in survival
study. In another set of experiments, the ED50 dose of Gu-4 for
survival was tested on a number of additional parameters. For the
measurements of plasma cytokines or lactic acid (LA) and
histological examination of lungs, animals were treated with saline
or Gu-4 (0.929 mg/kg) after the LPS challenge, and were killed at
0 hr (baseline), 1 hr, 2 hr, 4 hr, 6 hr, 8 hr and 10 hr (n=10 mice
at each time point), respectively.
Histological examination
Lung tissues on the right side were isolated from mice and fixed
in 10% formalin for 24 hrs at 4uC, embedded in paraffin and then
serially sectioned. The sections were stained with hematoxylin and
Figure 7. Effect of Gu-4 on survival of septic mice induced by
cecal ligation and puncture (CLP). CLP was performed as described
in Materials and Methods. Saline or Gu-4 (0.929 mg/kg per 3 hr)
treatment were performed separately in two groups of mice subjected
to CLP. Data represent the percentages of survival rates at the indicated
time points after CLP surgery; n=20 animals per group. A significant
increase of survival was found in the group treated with Gu-4 after CLP
surgery compared with the group treated with saline after CLP surgery,
*: p,0.05.
doi:10.1371/journal.pone.0030110.g007
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was evaluated by two investigators blinded to the treatment of
animals. Lung injury was assessed in sections using a four-category
scale system, including edema, hemorrhage, leukocyte infiltration
and alveolar septal thickening [39], to grade the degree of lung
injury in 8 fields. Each category was scored from 0 to 4
(0=normal; 1#25%; 2=25–50%; 3=50–75%; 4$75%); the
sum of each individual scores was used to represent the total lung
injury.
Measurement of LA in lung tissue
Lung tissues on the left side were collected from mice, weighed
and immediately homogenized individually with 0.9% saline at a
ratio of 1:9 (w/v) at 4uC. The homogenates were centrifuged
(3000 rpm for 10 mins) at 4uC and the supernatants were used for
assays. The protein content in the supernatant was determined by
Bradford assay [40]. The LA level in the supernatant was
measured by using a lactate assay kit (Nanjing Jiancheng
Bioengineering Institute, Nanjing, China). The LA level in lung
extracts was expressed as millimole LA per gram of protein.
Measurement of serum levels of TNF-a and IL-10
The concentrations of TNF-a and IL-10 in serum samples were
determined simultaneously by using a commercial multiplexing
assay kit (CBA kit 552364, BD Biosciences, San Jose, CA).
Samples and standards were prepared following the manufactur-
er’s instructions and analyzed on a BD FACScan equipped with
BD CellQuest and CBA software (BD Biosciences, Franklin Lakes,
NJ, USA).
Adhesion assay
To examine the effect of Gu-4 on leukocyte-endothelial
interaction under static condition, HUVECs (1610
5 cells per
well) were cultured in a 96-well culture plate (Greiner) to
confluence, followed by activation with TNF-a 10 u/ml (Bioworld
Technology, Inc. , St. Louis Park, MN, USA) for 24 h. Aliquots of
THP-1 cells (1610
5 cells per aliquot) were firstly stained with
Calcein-AM (8 mM) (C1359, Sigma) for 40 mins at 37uC, followed
by 15 mins treatment of LPS (1 mg/ml) or culture media without
LPS. After washed for three times, the THP-1 cells were subjected
separately to the treatments of Gu-4 (40 nmol/ml), b-lactose
(40 nmol/ml), CD11b antibody (4 mg/ml) (301214, Biolegend), or
saline for 10 mins. Then, the treated THP-1 cells were co-
incubated with HUVECs in HEPES CaMg buffer (0.05 M
HEPES, 0.15 M NaCl, 1 mM CaCl2, 1 mM MgCl2, pH 7.4) for
20 mins at 37uC. The non-adherent cells were removed by
washing with 16isotonic phosphate buffered saline (PBS) (pH 6.0).
The adherent cells were quantified by fluorescence measurement
with a fluorescence plate reader (Bio-Tek SynergyII) at 485 nm/
528 nm. The mean fluorescence intensity (MFI) of triplicate wells
was used for statistical analysis.
Transwell migration assay
To examine the effects of Gu-4 treatment on the migration
behavior of leukocyte, in vitro chemotaxis assays were performed
using 3.0 mm pore-size Transwell inserts (Millipore, PISP12R48)
in 24-well plates (Corning). HUVECs were cultured in inserts until
confluent, followed by stimulation with 10 u/ml of TNF-a for
24 hrs. After aspiration of the culture medium from the insert
without disturbing the endothelial monolayer, Calcein-AM stained
and LPS treated THP-1 cells were subjected to the treatments as
described in adhesion assay, and then put in the inserts (3610
5
cells/300 ml per insert). The lower well contained 500 ml of serum-
free RPMI 1640 with 100 ng/ml IL-8 (208-IL, R&D Systems,
Minneapolis, MN). The plates were incubated at 37uC for 4 hrs
before the inserts were carefully removed. The migrated cells were
determined by reading the fluorescence intensity of the lower
chamber with a fluorescence plate reader (Bio-Tek SynergyII) at
485 nm/528 nm. The MFI of triplicate wells was used for
statistical analysis. The absence of adherent cells to the
undersurface of the inserts was ascertained by light microscopy.
Measurement of CD11b expression by flow cytometry
To examine the effects of Gu-4 on the expression of CD11b,
heparinized whole blood samples were collected intravenously
from healthy donors. Briefly, blood samples were aliquoted (200 ml
per aliquot) and co-incubated with Gu-4 (40 nmol/ml) and LPS
(100 ng/ml) for 30 mins. Then the aliquots were further co-
incubated separately with PE-labeled anti-CD11b polyclonal
antibody (sc-1186, Santa Cruz, CA, USA) or PE-conjugated
monoclonal antibody CBRM1/5 (12-0113, eBioscience, San
Diego, CA, USA) that binds to the I domain of CD11b for
10 mins. Red blood cells in samples were lysed with lysis buffer
(KHCO3 1g ,N H 4Cl 8.3 g, EDTA-Na2 37 mg, add sterile water
to 1,000 ml, adjust pH to 7.2 with HCl) at a ratio of 1:10 (v/v).
After centrifugation at 1500 rpm for 5 mins, leukocytes were
pelleted and resuspended in 300 ml PBS. At least 5,000 cells were
analyzed using the Guava ExpressPro application (Guava
CytoSoft Software, version 4.2) on a Guava EasyCyte Flow
Cytometer (Guava Technologies). Non-specific fluorescence
background was evaluated by comparing the fluorescence detected
from the cells incubated with antibodies having crossmatched
isotypes.
Observation of CD11b distribution
CD11b distribution on leukocytes was observed by a Carl Zeiss
LSM 700 laser scanning confocal microscope (LSCM, Car Zeiss
Microimaging, Inc., Thornwood, NY, USA). Leukocytes obtained
and treated as described in flow cytometry assay were further
incubated with Qdot 655 secondary antibody (Q11022MP)
(Invitrogen, Eugene, OR, USA) for 1 hr at room temperature in
the dark. The cells were collected by centrifugation at 10006rpm
for 5 mins and washed for three times with PBS, then resuspended
in 300 ml PBS. A single drop of cell suspension was placed onto a
slide and a cover slip was applied on the top. Images were
obtained by using 488 nm Diode laser combined with a Plan-
Apochromat 636/1.40 Oil DIC M27 oil immersion objective lens.
Only those of cells with diameters about 10 mm were imaged. The
images captured by LSCM were analyzed by ZEN 2008 Light
Edition software. The two-dimensional intensity distribution of an
image was displayed in a pseudo 3D mode (2.5D filled view).
Western blotting
THP-1 cells that cultured in 24-well plate (3610
5 per well) were
stimulated with LPS (100 ng/ml), Gu-4 (40 nmol/ml), or both for
5, 10, 15, 20 min, respectively. Cells were then rinsed twice with
ice-cold PBS, and lysed with a lysis buffer (20 mM Tris, 135 mM
NaCl, 2 mM EDTA, 2 mM DTT, 25 mM b-glycerophosphate,
2 mM sodium pyrophosphate, 10% glycerol, 1% Triton X-100,
1 mM sodium orthovanadate, 10 mM NaF, pH 7.5) containing
10 mg/ml aprotinin, 10 mg/ml leupeptin, and 1 mM phenyl-
methylsulfonyl fluoride (PMSF). Lysates were cleared by centrifu-
gation (15 mins at 15,0006g, 4uC), diluted with 26SDS sample
buffer (0.5 M Tris-HCl (pH 6.8) 2 ml, 10% SDS 4 ml, glycerol
2 ml, b-mercaptoethanol 1 ml, bromophenol blue 1.5 mg, add
deionized water to 10 ml, store under 4uC), and boiled. Protein
extracts were resolved on 12% SDS polyacrylamide gel and
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Proteins of interest were visualized by probing the blots with
primary antibody against Syk (MAB88906) (Chemicon interna-
tional Inc., Temecula, CA, USA) or against phospho-Syk
(Tyr525/526) (#2711) (Cell Signaling Technology, Inc., Danvers,
MA, USA) and the secondary antibody flurophore-conjugated
IRDye800 (LI-COR Biosciences, Lincoln, NE), respectively.
Antibodies were diluted to a final concentration of 0.5 to 1 mg/
ml. The signal intensity was quantified by LI-COR Odyssey
Analysis software. Densitometric analysis of the expression level of
phosphorylated Syk on the immunoblots was normalized by that
of b-actin. Representative immunoblots from five independent
experiments are shown.
Effect of Gu-4 in the CLP model of polymicrobial sepsis
Mice were anesthetized with pentobarbital sodium (30 mg/kg)
(Sinopharm Chemical Reagent Co., Ltd., Shanghai, China).
Under aseptic conditions, a 1.5-cm midline laparotomy was
performed to allow exposure of the cecum. The cecum was tightly
ligated with a 3-0 silk suture placed at its base, and was perforated
twice with an 18-gauge needle. Then the cecum was gently
squeezed to extrude a small amount of feces from the perforation
sites. The laparotomy was closed with 4-0 silk sutures after the
cecum was returned to the peritoneal cavity [42]. Ten mice
underwent laparotomy but not cecum ligation and puncture were
taken as controls. The administration of saline solution or Gu-4
(0.929 mg/kg) to animals through i.p. (n=20 mice in each group)
was started after 3 hrs of surgery, and was continuously given
every 3 hrs for 72 hrs or until the death of individual. The survival
rates were monitored within 72 hrs.
Statistical analysis
Data are presented as mean 6 SD. Statistical analysis was
performed by statistics package for social science (SPSS) of 13.0-
version. One way analysis of variance followed by Student-
Newman-Keuls multiple comparison tests. Survival of mice was
analyzed with Kaplan–Meier survival analysis with the log-rank
test for between-group comparisons. p,0.05 was considered
statistically significant. ED50 of Gu-4 for LPS endotoxemia model
was determined by Probit analysis.
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